ArticleCureus2024

Acalabrutinib and Obinutuzumab for Chronic Lymphocytic Leukemia Complicated With Peripheral Neuropathy.

Taro Edahiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.